Oppenheimer Maintains Underperform Rating on Sun Healthcare Group

A report from Oppenheimer reiterates it Underperform rating on Sun Healthcare Group SUNH. The report states, “Adjusted results exclude a $317.1M non-cash charge related to the 2012 Medicare rate cuts, as well as a $2.4M restructuring charge tied to the mitigation efforts. The reimbursement headwinds persist for the industry, and we will await the call to see if management can shed more light with more than a month under the new reimbursement system." SUNH closed yesterday at $2.50.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: Analyst ColorEarningsNewsReiterationAnalyst RatingsOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!